Postoperative radiotherapy-induced morbidity in rectal cancer;Morbilidad de la radioterapia postoperatoria en el cáncer de recto

Revista Espanola de Enfermedades Digestivas

Volumn 96, Issue 11, 2004, Pages 765-772

  Garay Burdeos, Miguel ^a   Garcia Botella M ^a   Viciano Pascual, V ^a   Torregrosa Macias M D ^a   Aguilo Lucia J ^a   Ata, M ^a   Munoz Alonso M C ^a   Garcia del Cano J ^a  

^a Oncology Section   (Spain)

Author keywords

Chemo radiotherapy; Morbidity; Rectal cancer

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; FLUOROURACIL; FOLINIC ACID; LOPERAMIDE;

ACCURACY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DEFECATION; DIAPER; DIARRHEA; FECES INCONTINENCE; FEMALE; FOLLOW UP; HUMAN; INTESTINE FISTULA; INTESTINE FUNCTION; INTESTINE RESECTION; INTESTINE STENOSIS; LONG TERM CARE; MALE; MORBIDITY; PARENTERAL NUTRITION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RECTUM ANASTOMOSIS; RECTUM CANCER; RECTUM RESECTION; SKIN IRRITATION; TREATMENT INDICATION;

EID: 13444269284     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082004001100004     Document Type: Article

References (25)

1. Ooi BS, Tjandra JJ, Green MD. Morbidities of adjuvant chemotherapy and radiotherapy for resectable, rectal cancer. Dis Colon Rectum 1999; 42: 403-18.
2. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465-72.
3. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-304.
4. Bosset JF, Mantion G, Lorchel F, Magnin V, Pelissier EP, Gerard JP, et al. Adjuvant and neoadjuvant radiation Therapy for rectal cancer. Sem Oncol 2000; 27: 60-5.
5. Martín de Vidales C, Cerezo L, Vazquez de la Torre ML, Zapatero A, Del Cerro E, Pinar B, et al. Estudio, comparativo en el adenocarcinoma de recto: radioterapia preoperatoria o postoperatoria. Rev Esp Enferm Dig 1995; 87: 199-204.
6. Sauer R. Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer. Pathol Oncol Res 2002; 8: 7-17.
7. Marjinen CAM, Glimelius B. The role of radiotherapy in rectal cancer. Eur J Cancer 2002; 38: 943-52.
8. Sociedad Valenciana de Cirugía. Guía de práctica clínica en el cáncer colorrectal. Generalitat Valenciana. Consellería de Sanitat. Valencia, 2002.
9. Tratamiento adyuvante del cáncer colorrectal. En: Lledó S, ed. Cirugía Colorrectal. Asociación Española de Cirujanos. Madrid: Arán Ediciones. 2000.
10. Glimelius B. Radiotherapy in rectal cancer. Br Med Bull 2002; 64: 141-57.
11. Minsky BD, Coia L, Haller DG, Hoffman J, John M, Landry J, et al. Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 patterns of care process survey. J Clin Onc 1998; 16: 2542-7.
12. Heald RJ, Moran BJ, Ryall RDH, Sexton R, MacFarlane JK, et al. Rectal cancer. The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-9.
13. Büllow S, Christensen IJ, Harling H, Kronborg O, Fenger C. Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 2003; 90: 974-80.
14. Reis ED, Vine AJ, Heimann T. Radiation damage to the rectum and anus: pathophysiology, clinical features and surgical implications. Colorectal Dis 2002; 4: 2-12.
15. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994; 220: 676-82.
16. Nathanson DR, Espat NJ, Nash GM, D'Alessio M, Thaler H, Minsky BD, et al. Evaluation of preoperative and postoperative radiotherapy on long-term functional results of straight coloanal anastomosis. Dis Colon Rectum 2003; 46: 888-94.
17. Coia LR, Gunderson LL, Haller D, Hoffman J, Mohiuddin M, Tepper JE, et al. Outcomes of patients receiving radiation for carcinoma of the rectum. Results of the 1988-1989 patterns of care study. Cancer 1999; 86: 1952-8.
18. Arraras JI, Vera R, Manterola A, Martínez M, Arias F, Martínez E, et al. El cuestionario de calidad de vida para cáncer colorrectal. EORTC QLQCR38. Estudio, de validación para nuestro país. Oncología 2003; 26 (9): 285-92.
19. Marijnen CAM, Kapiteijn E, Van de Velde CJH, Martijn H, Steup WH, Wiggers T, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 20: 817-25.
20. Ammann K, Kirchmayr W, Klaus A, Mühlmann G, Kafka R, Oberwalder M, et al. Impact of neoadjuvant chemoradiation on anal sphincter function in patients with carcinoma of the midrectum and low rectum. Arch Surg 2003; 138: 257-61.
21. Dahlberg M, Glimelius B, Pahlman L. Changing strategy for rectal cancer is associated with improve outcome. Br J Surg 1999; 86: 379-84.
22. Wiggers T, Van de Velde CHJ. Reduction by half. The need for standarised surgical technique in studies of radiotherapy for rectal cancer. Eur J Surg 1999; 165: 407-9.
23. MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
24. Kapiteijn E, Kranenbarg EK, Steup WH, et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Eur J Surg 1999; 165: 410-20.
25. Simunovic M, Sexton R, Rempel E, Moran BJ, Heald RJ. Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg 2003; 90: 999-1003.